Fortune Brands Innovations heads into the week after its Q1 report with analysts trimming numbers in unison and short sellers sitting at their most committed level in months.
The most striking development this week came from the Street, not the tape. Every analyst who touched FBIN after Wednesday's earnings report lowered their price target — no exceptions. UBS kept its Buy rating but cut the target from $67 to $63. RBC Capital maintained Outperform while slipping from $56 to $50. Truist dropped from $55 to $45 on a Hold. Evercore, whose target was already trimmed to $41 in mid-April, moved again to $38 — now just a few dollars above the current price of $37.98. The direction of travel is uniform: the Street still sees upside from here, with the mean target at $47.71, but the magnitude of that upside has been steadily eroding since early April. No firm upgraded, no firm raised a target.
That post-earnings tone explains the positioning picture. Short interest has climbed roughly 30% over the past month to 7.65% of the free float — a meaningful jump from about 5.9% in late March. The build began in earnest around April 10, when SI stepped up from roughly 5.8% to 7.1% almost overnight, and has held near those elevated levels since. The stock fell nearly 5% on the day of the earnings release itself, adding to a 4.8% weekly decline that left it underperforming close peers. dropped 2.5% on the day but finished the week up over 2%. shed around 2% on the day, down 1.8% for the week — still better than FBIN's weekly performance. Borrow conditions remain loose, however: cost to borrow is just 0.51% and availability is ample, meaning there's no friction slowing short sellers down and no obvious squeeze pressure building.
Options positioning tells a consistent story. The put/call ratio has been running persistently above 1.0 for the past month, and at 1.08 it sits almost exactly in line with its 20-day average — meaning this is the baseline, not an escalation. There's no elevated z-score spike here; investors have been in defensive mode on FBIN for weeks. That persistence, rather than any single spike, is the signal.
The factor picture adds nuance. The dividend score ranks in the 96th percentile — a reflection of the company's yield discipline relative to peers — and the EV/EBIT score at 83 suggests the market is not attaching a demanding multiple to earnings power. The PE ratio has drifted down over 30 days to around 11x. EPS momentum scores, at 18 and 10 on both 30-day and 90-day horizons, are weak. The analyst recommendation diff scores just 6 out of 100, confirming that the consensus leans cautious rather than constructive. Bulls point to margin resilience and potential rate-cut tailwinds; bears flag a still-sluggish repair-and-remodel backdrop and ongoing multiple compression since the cabinets spin-off.
Institutional ownership adds an interesting undercurrent. Pictet Asset Management added over 3.3 million shares as of the March quarter-end, lifting its stake to 6.5% of shares. Edward Garden disclosed a new 2.94% position as of mid-March. Those are two fresh hands entering at prices materially above current levels. Whether those positions get tested in coming weeks depends in large part on how the housing data and rate expectations develop into the next scheduled earnings print on July 28.
See the live data behind this article on ORTEX.
Open FBIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
